11/6
11:46 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/6
11:46 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
12:45 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
12:45 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
12:09 pm
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/4
11:24 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
11:24 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
11:02 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
11:02 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
10:38 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
10:38 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
08:09 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $154.00 price target on the stock.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $154.00 price target on the stock.
11/4
04:22 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/4
04:22 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
10/20
11:23 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
10/20
11:23 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
10/20
08:21 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/20
08:21 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/2
07:19 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) was upgraded by analysts at B. Riley to a "strong-buy" rating.
10/2
07:19 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) was upgraded by analysts at B. Riley to a "strong-buy" rating.
10/1
07:05 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
10/1
07:05 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
10/1
05:55 am
axsm
Axsome Therapeutics initiated with a Buy at B. Riley
Low
Report
Axsome Therapeutics initiated with a Buy at B. Riley
10/1
05:55 am
axsm
Axsome Therapeutics initiated with a Buy at B. Riley
Low
Report
Axsome Therapeutics initiated with a Buy at B. Riley
9/30
08:47 pm
axsm
Axsome Therapeutics initiated with a Buy at B. Riley
Low
Report
Axsome Therapeutics initiated with a Buy at B. Riley